CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Shares withheld for taxes Chief Scientific Officer gave up 942 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,085 shares (to pay taxes)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Chief Accounting Officer gave up 362 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief of Staff gave up 2,622 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 2,545 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 9,088 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 8,690 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 7,690 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 117,680 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,539 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief of Staff gave up 4,989 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 6,060 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 7,725 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 13,308 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer acquired 63,145 shares (grant or award)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 9,576 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,217 shares (to pay taxes)
Page 8 of 104 · 2,077 filings